Clinical Scorecard: Clinical Characteristics and Contributing Factors of Plastic Bronchitis in Pediatric Patients with Mycoplasma pneumoniae Pneumonia and Pulmonary Consolidation: A Prospective Cohort Analysis

At a Glance

Key Highlights

• Higher rates of respiratory distress in PB group
• Longer hospital stays and fever durations in PB patients
• Significant predictors for PB include fever duration, D-dimer, and LDH levels
• Bootstrap validation shows good model stability for predicting PB
• Optimal cutoffs identified for fever duration, D-dimer, and LDH

Guideline-Based Recommendations

Diagnosis

• Use bronchoscopy for diagnosis in hospitalized children with MPP and pulmonary consolidation

Management

• Consider early anti-inflammatory therapy or bronchoscopic intervention to improve outcomes

Monitoring & Follow-up

• Monitor fever duration, D-dimer, and LDH levels for risk assessment of PB

Risks

• Increased risk of PB associated with prolonged fever and elevated inflammatory markers

Patient & Prescribing Data

Children with Mycoplasma pneumoniae pneumonia and pulmonary consolidation

Focus on managing inflammation and monitoring coagulation markers

Clinical Best Practices

• Assess fever duration and inflammatory markers in pediatric pneumonia cases
• Implement early intervention strategies for high-risk patients
• Utilize multivariate analysis for risk stratification in clinical settings

Related Resources & Content

• Clinical Characteristics and Contributing Factors of Plastic Bronchitis